Javascript must be enabled to continue!
Immune-related genes probably increase the occurrence of Interstitial Lung Disease in Dermatomyositis
View through CrossRef
Abstract
Background Interstitial lung disease (ILD) is one of the significant complications of dermatomyositis (DM), but the mechanisms by which it occurs remain incompletely elucidated. This study aimed to explore further the possible genetic mechanisms by which this complication occurs.
Methods Gene expression profiles for dermatomyositis (GSE39454, GSE46239, GSE143323) and interstitial lung disease (GSE32537, GSE110147, GSE150910) were downloaded from the Gene Expression Omnibus (GEO) database. After identifying common differentially expressed genes (DEGs) to dermatomyositisand interstitial lung disease using the "limma" R package and the "VennDiagram" R package, functional annotation, relationship to immune cell infiltration, identification of transcription factors (TFs). We also collected clinical cases of dermatomyositis-associated interstitial lung disease (DM-ILD), including 3 cases of rapidly progressive interstitial lung diseases and 3 cases of none-rapidly progressive interstitial lung diseases, and explored whether there were differences in serum lymphocyte subpopulations.
Results A total of 4 common DEGs (SLAMF7, SPP1, TDO2, and VCAM1) were screened and GO enrichment analysis showed that these genes were mainly enriched in T cell activation, regulation of lymphocyte activation, lymphocyte differentiation, leukocyte proliferation and regulation of T cell activation. In terms of KEGG pathways, the three significantly enriched pathways were the PI3K-Akt signaling pathway, MAPK signaling pathway, and Cytokine-cytokine receptor interaction. In lung and muscle tissues, 21 and 3 TFs may regulate the expression of these genes, respectively. Finally, by analysing the serum lymphocyte subpopulations, we also found a decrease in the absolute number of CD8+ T cells and an increase in the CD4+ /CD8+ T cell ratio in dermatomyositis combined with rapidly progressive interstitial lung disease.
Conclusion These common pathways and key genes may provide new ideas for further research into DM-ILD.
Title: Immune-related genes probably increase the occurrence of Interstitial Lung Disease in Dermatomyositis
Description:
Abstract
Background Interstitial lung disease (ILD) is one of the significant complications of dermatomyositis (DM), but the mechanisms by which it occurs remain incompletely elucidated.
This study aimed to explore further the possible genetic mechanisms by which this complication occurs.
Methods Gene expression profiles for dermatomyositis (GSE39454, GSE46239, GSE143323) and interstitial lung disease (GSE32537, GSE110147, GSE150910) were downloaded from the Gene Expression Omnibus (GEO) database.
After identifying common differentially expressed genes (DEGs) to dermatomyositisand interstitial lung disease using the "limma" R package and the "VennDiagram" R package, functional annotation, relationship to immune cell infiltration, identification of transcription factors (TFs).
We also collected clinical cases of dermatomyositis-associated interstitial lung disease (DM-ILD), including 3 cases of rapidly progressive interstitial lung diseases and 3 cases of none-rapidly progressive interstitial lung diseases, and explored whether there were differences in serum lymphocyte subpopulations.
Results A total of 4 common DEGs (SLAMF7, SPP1, TDO2, and VCAM1) were screened and GO enrichment analysis showed that these genes were mainly enriched in T cell activation, regulation of lymphocyte activation, lymphocyte differentiation, leukocyte proliferation and regulation of T cell activation.
In terms of KEGG pathways, the three significantly enriched pathways were the PI3K-Akt signaling pathway, MAPK signaling pathway, and Cytokine-cytokine receptor interaction.
In lung and muscle tissues, 21 and 3 TFs may regulate the expression of these genes, respectively.
Finally, by analysing the serum lymphocyte subpopulations, we also found a decrease in the absolute number of CD8+ T cells and an increase in the CD4+ /CD8+ T cell ratio in dermatomyositis combined with rapidly progressive interstitial lung disease.
Conclusion These common pathways and key genes may provide new ideas for further research into DM-ILD.
Related Results
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Time to Start Up: CT-Basted Radiomics in Children’s Lung Diseases
Radiomics is a new interdisciplinary field and a fusion product consisting by large data technology and medical image to aid diagnosis. Radiomics can gather information from differ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Dermatomyositis Disease in Dogs
Dermatomyositis Disease in Dogs
Canine dermatomyositis is an inflammatory vasculopathy from skin and muscles, with cutaneous manifestations involving face, ears, tail and distal ends over bony prominences. The mu...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...
Interstitial Lung Diseases and Non-Small Cell Lung Cancer: Particularities in Pathogenesis and Expression of Driver Mutations
Interstitial Lung Diseases and Non-Small Cell Lung Cancer: Particularities in Pathogenesis and Expression of Driver Mutations
Introduction: Interstitial lung diseases are a varied group of diseases associated with chronic inflammation and fibrosis. With the emerging and current treatment options, survival...
Understanding cystic lung lesions in smokers with interstitial lung disease: radiologic–pathological correlation
Understanding cystic lung lesions in smokers with interstitial lung disease: radiologic–pathological correlation
Abstract
Due to destructive, fibrotic, and remodeling mechanisms, we can find a varied constellation of aerated and cystic lung lesions in smoker patients with intersti...
Interstitial lung disease pathology in systemic sclerosis
Interstitial lung disease pathology in systemic sclerosis
Interstitial lung disease is a relatively frequent manifestation of systemic sclerosis with approximately one-third of patients developing clinical restrictive lung disease. Fibrot...

